Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 105 clinical trials
featured
Heart Valve Disease – Aortic and Mitral

months, 1 year, 18 months, and annually through 10 years. Randomly assigned (50% to either group) Treatment of Aortic Stenosis with either Transcatheter Aortic Valve Replacement (TAVR) device or

stenosis
aortic valve replacement
  • 776 views
  • 05 Feb, 2021
  • 1 location
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.

  • 0 views
  • 21 Jul, 2021
  • 1 location
Portico NG Approval Study

The purpose of this clinical study is to evaluate the acute safety and effectiveness of the next-generation Portico NG Transcatheter Aortic Heart Valve as assessed by the rate of all-cause mortality at 30 days and the rate of moderate or greater paravalvular leak at 30 days in a high or …

  • 118 views
  • 17 Mar, 2021
  • 21 locations
O2 Tension During TAVI

group after transcatheter aortic valve replacement.

  • 7 views
  • 26 Jan, 2021
  • 1 location
European Study Evaluating the EMBLOK Embolic Protection System During TAVR

The primary objective is to evaluate the performance and the treatment effect of the use of the Emblok embolic protection system use during transcatheter aortic valve replacement with respect to

transcatheter aortic valve implant
aortic valve replacement
  • 0 views
  • 16 May, 2021
  • 3 locations
Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation

Transcatheter Aortic Valve Implantation (TAVI) according to standard clinical practice. Patients have to continue with a specific pharmacological treatment (antiplatelet agents) to avoid possible complications

  • 0 views
  • 05 Aug, 2021
  • 1 location
Sedation or General Anesthesia During TAVR

Transcatheter aortic valve replacement TAVR is become the reference method for patients with severe aortic stenosis who are contraindicated or at risk for surgical aortic replacement. Initially

  • 0 views
  • 28 Jan, 2021
  • 1 location
  • 0 views
  • 05 Jul, 2021
  • 1 location
Comparison of Eligible TAVI-valves - Cohort B

The study performs head-to-head comparison of two TAVI-valves: Sapien and Myval.

  • 0 views
  • 25 Jan, 2021
  • 1 location
Transcatheter Aortic Valve Replacement System Pivotal Trial

Prospective, randomized, unblinded, multi-center investigational study with enrollment at up to 45 investigational sites. The study is designed to compare the study device (Direct Flow Medical Transcatheter Aortic Valve System) composite event rate to a blended commercial comparator (using approved Medtronic self-expanding bioprosthesis or Edwards balloon-expandable bioprosthesis) in high and …

aortic valve replacement
transcatheter aortic valve implantation
symptomatic aortic stenosis
  • 1 views
  • 21 Jan, 2021
  • 2 locations